Contribute Try STAT+ Today

Good morning, everyone, and nice to see you again. A warm and shiny sun is enveloping the Pharmalot campus, which is exceedingly quiet as our shortest person sleeps in and the other short one has departed for the usual gainful employment. Moreover, the official mascots are snoozing happily in various corners. As for us, yes, we are firing up the coffee kettle once again and digging in for another busy day of phone calls, meetings, and, of course, research. Meanwhile, here are some tidbits to help you on your own journey. Hope it goes well, and please do keep in touch …

Abbvie (ABBV) is claiming the National Health Service in England breached procurement rules during a process seeking suppliers for hepatitis C treatment, Health Service Journal reports. The procurement, described by NHS England as the single largest medicines procurement ever done by the NHS, was launched in the spring and its estimated value is in the hundreds of millions of dollars. The procurement was launched in a bid to lower the cost of hepatitis C drugs, but Abbvie alleged NHS England breached its duty to treat all bidders fairly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.